Earnings History Data for Harrow, Inc. (HROW) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Harrow, Inc.

Harrow Health Inc. owns a portfolio of healthcare businesses, including an ophthalmology pharmaceutical compounding business, ImprimisRx. The company holds Eton Pharmaceuticals, Surface Pharmaceuticals, Melt Pharmaceuticals, Mayfield Pharmaceuticals and Radley Pharmaceuticals as subsidiaries. Harrow Health Inc., formerly known as Imprimis Pharmaceuticals Inc., is based in San Diego, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
27-03-2025	AH		HROW	Harrow, Inc.	1,030	0.25	0.11	0.00	Harrow Health Non-GAAP EPS of $0.40 beats by $0.27, revenue of $66.83M beats by $5.03M [3/27/2025 4:59 PM]	26.09	-1.78 (-6.37%)	30.49	2.62 (9.40%)	9.86 - 59.23	1,495,137	790,000	31,093
Harrow Health Non-GAAP EPS of $0.40 beats by $0.27, revenue of $66.83M beats by $5.03M [3/27/2025 4:59 PM] Harrow Announces Fourth-Quarter and Year-End 2024 Audited Financial Results [2025-03-27 04:01PM] Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025 [2025-03-27 10:45AM] Harrow Inc.: Roll The Dice For Strong Upside Prospects As Earnings Ramp [2025-03-28 01:39PM] Harrow (HROW) Q4 Earnings and Revenues Top Estimates [Mar-27-25 06:45PM]
13-11-2024	AH		HROW	Harrow, Inc.	1,850	-0.12	-0.05	-0.09	Harrow Health Non-GAAP EPS of -$0.05 misses by $0.12, revenue of $49.26M misses by $3.55M [11/13/2024 4:37 PM]	42.41	-9.39 (-18.14%)	42.00	-9.80 (-18.92%)	7.60 - 59.23	2,114,912	530,000	172,742
Harrow Health Non-GAAP EPS of -$0.05 misses by $0.12, revenue of $49.26M misses by $3.55M [11/13/2024 4:37 PM] Harrow stock plunges 20% on weaker-than-expected Q3 earnings [11/13/2024 6:08 PM] Harrow Announces Third Quarter 2024 Financial Results [2024-11-13 04:34PM] Harrow Inc (HROW) Q3 2024 Earnings Report Preview: What To Look For [2024-11-13 07:16AM] Harrow Launches Access and Affordability Program with Price Reductions for Branded Products [2024-11-13 07:00AM] Harrow Announces Market Access Wins for VEVYE [Nov-12-24 07:00AM]
07-08-2024	AH		HROW	Harrow, Inc.	835.01	-0.13	-0.25	-0.02	Harrow Health Non-GAAP EPS of -$0.06 beats by $0.05, revenue of $48.9M beats by $6.39M [8/7/2024 4:55 PM]	33.88	11.90 (54.14%)	30.75	8.77 (39.90%)	7.60 - 35.23	4,298,481	410,000	265,007
Harrow Health Non-GAAP EPS of -$0.06 beats by $0.05, revenue of $48.9M beats by $6.39M [8/7/2024 4:55 PM]
13-05-2024	AH		HROW	Harrow, Inc.	363.88	-0.28	-0.25	-0.03	Harrow Health Non-GAAP EPS of -$0.28 misses by $0.07, revenue of $34.59M misses by $2.68M [5/13/2024 4:19 PM]	16.18	4.11 (34.05%)	14.50	2.43 (20.13%)	7.60 - 24.19	2,469,290	410,000	187,689
Harrow Health Non-GAAP EPS of -$0.28 misses by $0.07, revenue of $34.59M misses by $2.68M [5/13/2024 4:19 PM]
19-03-2024	PM		HROW	Harrow, Inc.	368.39	-0.27	0.00	0.07	Harrow Health Non-GAAP EPS of -$0.20 misses by $0.15, revenue of $36.36M misses by $1.5M [3/20/2024 1:11 AM]	10.51	-0.14 (-1.31%)	9.50	-1.15 (-10.80%)	7.60 - 28.25	2,300,960	350,000	296,277
Harrow Health Non-GAAP EPS of -$0.20 misses by $0.15, revenue of $36.36M misses by $1.5M [3/20/2024 1:11 AM]
13-11-2023	AH		HROW	Harrow, Inc.	450.18	-0.09	0.03	-0.06	Harrow Health GAAP EPS of -$0.13 misses by $0.17, revenue of $34.3M misses by $3.28M [11/13/2023 4:08 PM]	8.22	-4.61 (-35.93%)	9.69	-3.14 (-24.47%)	7.60 - 28.25	6,754,293	660,000	171,279
Harrow Health GAAP EPS of -$0.13 misses by $0.17, revenue of $34.3M misses by $3.28M [11/13/2023 4:08 PM] Biggest stock movers today: Home Depot, Fisker, Snap, Beauty Health Company and more [11/14/2023 9:34 AM] Harrow stock tumbles 38% in wake of Q3 report, revised guidance [11/14/2023 1:31 PM]
09-08-2023	AH		HROW	Harrow Health, Inc.	629.25	-0.02	0.00	0.01	Harrow Health Non-GAAP EPS of -$0.02, revenue of $33.5M beats by $2.46M [8/9/2023 4:20 PM]	16.76	-3.04 (-15.35%)	20.05	0.25 (1.26%)	7.12 - 28.25	1,796,533	330,000	29,620
Harrow Health Non-GAAP EPS of -$0.02, revenue of $33.5M beats by $2.46M [8/9/2023 4:20 PM] Harrow Health off 13% as 2023 revenue, EBITDA forecasts miss consensus midpoint [8/10/2023 1:56 PM]
11-05-2023	AH	4:05 PM ET (May 11)	HROW	Harrow Health, Inc.	841.49	-0.03	-0.06	0.03	Harrow Health Non-GAAP EPS of -$0.03, revenue of $26.1M beats by $1.11M [5/11/2023 4:04 PM]	21.91	-5.16 (-19.04%)	24.80	-2.27 (-8.39%)	5.40 - 28.25	2,505,354	350,000	5,199
Harrow Health Non-GAAP EPS of -$0.03, revenue of $26.1M beats by $1.11M [5/11/2023 4:04 PM] Harrow Health falls 23% despite Q1 revenue beat [5/12/2023 2:12 PM]
23-03-2023	AH	4:05 PM ET (Mar 23)	HROW	Harrow Health, Inc.	489.15	0.07	-0.15	-0.01	Harrow Health Non-GAAP EPS of $0.07, revenue of $20.3M misses by $1.43M [3/23/2023 4:09 PM]	18.42	1.17 (6.78%)	18.00	0.75 (4.35%)	5.40 - 20.31	373,854	440,000	4,553
Harrow Health Non-GAAP EPS of $0.07, revenue of $20.3M misses by $1.43M [3/23/2023 4:09 PM]
14-11-2022	AH	4:00 PM ET (Nov 14)	HROW	Harrow Health, Inc.	304.81	-0.06	0.02	0.05	Harrow Health GAAP EPS of -$0.24 misses by $0.23, revenue of $22.8M misses by $0.34M [11/14/2022 4:11 PM]	11.04	-0.56 (-4.81%)	0.0	0.0 (0.00%)	5.40 - 13.29	275,339	150,000	0
Harrow Health GAAP EPS of -$0.24 misses by $0.23, revenue of $22.8M misses by $0.34M [11/14/2022 4:11 PM] Harrow Announces Third Quarter 2022 Financial Results [Nov-14-22 04:05PM]
09-08-2022	AH	4:00 PM ET (Aug 9)	HROW	Harrow Health, Inc.	190.84	0.01	0.00	-0.11		7.58	0.62 (8.91%)	0.0	0.0 (0.00%)	5.40 - 12.99	109,965	40,000	0
Harrow Health Q2 Non-GAAP EPS down Y/Y, revenue up [8/9/2022 4:04 PM]
05-05-2022	AH	4:00 PM ET (May 5)	HROW	Harrow Health, Inc.	185.16	0.03	-0.04	0.11	Harrow Health Non-GAAP EPS of $0.03 beats by $0.07, revenue of $22.12M beats by $2.64M [5/5/2022 5:03 PM]	6.88	0.46 (7.17%)	6.61	0.0 (0.00%)	6.25 - 12.99	57,950	150,000	151
Harrow Health Non-GAAP EPS of $0.03 beats by $0.07, revenue of $22.12M beats by $2.64M [5/5/2022 5:03 PM] Melt Pharmaceuticals Announces MELT-210 Top-Line Results of Phase 1 Pharmacokinetics (PK) Study for Procedural Sedation [May-04-22 08:00AM] Harrow Health Announces First Quarter 2022 Financial Results [May-05-22 04:01PM] Is Harrow Health, Inc.'s (NASDAQ:HROW) Shareholder Ownership Skewed Towards Insiders? [May-06-22 09:01AM]
10-03-2022	AH	4:00 PM ET (Mar 10)	HROW	Harrow Health, Inc.	193.16	-0.01	0.08	0.07	Harrow Health GAAP EPS of -$0.27 misses by $0.23, revenue of $20.2M beats by $0.84M [3/10/2022 4:02 PM]	7.30	0.23 (3.22%)	6.75	-0.32 (-4.53%)	6.00 - 12.99	109,758	60,000	37,651
Harrow Health GAAP EPS of -$0.27 misses by $0.23, revenue of $20.2M beats by $0.84M [3/10/2022 4:02 PM] Melt Pharmaceuticals Names Experienced Executive Brad Osborne as Chief Financial Officer [Mar-10-22 08:00AM] Harrow Health Announces Fourth Quarter and Year-End 2021 Financial Results [Mar-10-22 04:01PM]
09-11-2021	AH	4:00 PM ET (Nov 9)	HROW	Harrow Health, Inc.	322.73	0.05	0.03	0.04	Harrow Health EPS misses by $0.28, beats on revenue [11/9/2021 4:53 PM]	10.93	-0.55 (-4.79%)	0.0	0.0 (0.00%)	5.13 - 12.99	299,072	170,000	0
Harrow Health EPS misses by $0.28, beats on revenue [11/9/2021 4:53 PM] Harrow Health Announces Third Quarter 2021 Financial Results [Nov-09-21 04:01PM] Harrow Health (HROW) Beats Q3 Earnings and Revenue Estimates [Nov-09-21 06:25PM]
10-08-2021	AH	4:00 PM ET (Aug 10)	HROW	Harrow Health, Inc.	243.49	-0.11	0.04	-0.13	Harrow Health EPS misses by $0.10, beats on revenue [8/10/2021 4:17 PM]	9.03	0.01 (0.11%)	9.20	0.18 (2.00%)	4.65 - 11.24	173,717	160,000	320
Harrow Health EPS misses by $0.10, beats on revenue [8/10/2021 4:17 PM] Harrow Health Announces Second Quarter 2021 Financial Results [Aug-10-21 04:01PM] Harrow Health (HROW) Reports Q2 Loss, Tops Revenue Estimates [Aug-10-21 05:15PM]
11-05-2021	AH	4:00 PM ET (May 11)	HROW	Harrow Health, Inc.	217.18	0.11	0.04	-0.05	Harrow Health EPS beats by $0.05, beats on revenue [5/11/2021 4:02 PM]	9.10	1.30 (16.67%)	8.00	0.20 (2.56%)	3.63 - 11.10	1,107,861	220,000	2,003
Harrow Health EPS beats by $0.05, beats on revenue [5/11/2021 4:02 PM] Harrow Health, Inc. to Host Earnings Call [May-11-21 02:45PM] Harrow Health Announces Record First Quarter 2021 Financial Results [May-11-21 04:01PM]
08-03-2021	AH	4:00 PM ET (Mar 8)	HROW	Harrow Health, Inc.	197.47	0.07	0.00	0.10	Harrow Health EPS beats by $0.02, beats on revenue [3/8/2021 4:04 PM]	8.24	0.22 (2.68%)	0.0	0.0 (0.00%)	3.33 - 11.10	383,204	243,768	0
Harrow Health EPS beats by $0.02, beats on revenue [3/8/2021 4:04 PM] Harrow Health (HROW) Lags Q4 Earnings Estimates [Mar-08-21 06:05PM] Harrow Health Announces Fourth Quarter and Year-End 2020 Financial Results [Mar-08-21 04:01PM] Harrow Health, Inc. to Host Earnings Call [Mar-08-21 01:45PM]
09-11-2020	AH	4:00 PM ET (Nov 9)	HROW	Harrow Health, Inc.	125.68	0.04	-0.11	-0.29	Harrow Health EPS of $0.32 [11/9/2020 4:41 PM]	6.18	1.09 (21.41%)	5.09	0.0 (0.00%)	3.33 - 7.92	277,673	155,343	300

10-08-2020	AH	4:00 PM ET (Aug 10)	HROW	Harrow Health, Inc.	147.31	-0.13	-0.21	-0.09	Harrow Health EPS beats by $0.09, beats on revenue [8/10/2020 4:08 PM]	6.42	0.51 (8.63%)	5.91	0.0 (0.00%)	3.33 - 7.92	190,344	127,321	629